Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    22571202 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
Conditions: Myeloma;   Venous Thromboembolism
Intervention: Drug: Apixaban
2 Recruiting Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Lenalidomide
3 Active, not recruiting Maintenance Therapy Using Lenalidomide in Myeloma
Condition: Myeloma
Interventions: Drug: lenalidomide;   Drug: placebo

Indicates status has not been verified in more than two years